Urgent.News

What's breaking now, across thousands of outlets.

AI

OpenAI acquires Orchestra Bio

OpenAI is acquiring Orchestra Bio to bring AI-powered operations to life sciences R&D, helping biopharma teams accelerate drug development and advance new treatments.

We haven't written up this one. OpenAI has the full story — the link below goes straight to it.

Also reported by 1 other outlet

Read the original at openai.com →

More in AI

More from Tuesday 20 October →